long-term effects of glp-1 receptor agonists liraglutide (GLP-1 agonist) – Efficacy and Adverse The Impact of Glucagon-like Peptide-1
Description
Phase 3 TRIUMPH-4 (topline) In Lillys topline summary, the most common adverse events included nausea, diarrhoea, constipation and vomiting (typical of incretin-based therapies)
Severe nausea, vomiting, or dizzinessseek immediate help
The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
p = 0.271)
He receives consulting fees from Medtronic, Stryker, Imperative Care, Microvention, MIVI Neurovascular, Cerenovus, Asahi, and Balt
Acute tubulointerstitial nephritis following treatment with exenatide
